Madrigal Pharmaceuticals (1MDGL.MI) Q3 2026 Earnings

11AugConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
-4.42
-3.2
-1.98
-0.76

Details

Expected EPS
-2.1520031856
Actual EPS
N/A
Surprise EPS
2.15
Surprise Percent
+100%

Description

Madrigal Pharmaceuticals (1MDGL.MI) will report earnings of for Q3 2026 on August 11, 2026.

0 Comments

Share your thoughts